My Blog List

Monday, November 19, 2012

Avastin misses key data point in brain cancer study - geo.tv

Avastin misses key data point in brain cancer study - geo.tv
 

HEALTH AWARENESS:
Swiss drugmaker Roche's cancer drug Avastin failed to make a statistically significant difference to survival rates of patients with a common form of brain cancer in a late-stage study, the c
Hompany said on Saturday.

       - A.R.Shams's Reflection - Press and Online Publications.arshamssreflection.blogspot.com

No comments:

Post a Comment